Marata, Flordiliza .

HRN: 25-96-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2024
CEFUROXIME 1.5GM (VIAL)
12/21/2024
12/21/2024
IV
1.5gm
LD
For TAHBSO
Waiting Final Action 
12/22/2024
CEFUROXIME 1.5GM (VIAL)
12/22/2024
12/22/2024
IV
1.5gm
LD
For TAHBSO
Waiting Final Action 
12/22/2024
CEFUROXIME 500MG (TAB)
12/22/2024
12/28/2024
PO
500mg
BID
SP TAHBS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: